Literature DB >> 19747736

Hypokalemia is associated with lengthening of QT interval in psychiatric patients on admission.

Benoit Trojak1, Karine Astruc, Jean-Michel Pinoit, Jean-Christophe Chauvet-Gelinier, Eddy Ponavoy, Bernard Bonin, André Gisselmann.   

Abstract

Several studies have revealed a relatively high frequency of hypokalemia in the general psychiatric population. This may be explained by adrenergic stimulation observed in the acute phase of psychiatric disorders. Little is known about the effects of hypokalemia on cardiac repolarisation in these circumstances. The current study was designed to determine if the hypokalemia observed among patients with acute psychiatric disorders can cause significant QT interval prolongation, and thus increase the risk of ventricular arrhythmia. Electrocardiograms were obtained in 282 non-selected patients admitted to a psychiatric unit. Heart-rate adjusted QT intervals (QTc) were compared to serum potassium levels and to other risk factors for QT prolongation (bradycardia, age, gender, and administration of antipsychotics). Hypokalemia, diagnosed in more than 11% of the patients, was associated with a significantly longer QTc interval (means 423.5+/-40 ms vs 408.5+/-31 ms), as was female sex. Multiple linear regression analysis on the studied risk factors revealed that only hypokalemia and female sex were independently associated with lengthening of the QT interval. According to our results, hypokalemia seems to be one of the most important risk factors for QT prolongation. We therefore strongly recommend that psychiatric patients should be screened for hypokalemia on admission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747736     DOI: 10.1016/j.psychres.2008.06.031

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Hypokalemia-induced T-U fusion.

Authors:  Hesham R Omar
Journal:  Intern Emerg Med       Date:  2011-12-03       Impact factor: 3.397

Review 2.  Pathophysiology and management of hypokalemia: a clinical perspective.

Authors:  Robert J Unwin; Friedrich C Luft; David G Shirley
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

3.  Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.

Authors:  Anita N Bindraban; José Rolvink; Florine A Berger; Patricia M L A van den Bemt; Aaf F M Kuijper; Ruud T M van der Hoeven; Aukje K Mantel-Teeuwisse; Matthijs L Becker
Journal:  Int J Clin Pharm       Date:  2018-07-26

4.  Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting.

Authors:  Keith A Marill; Emily S Miller
Journal:  J Electrocardiol       Date:  2017-02-10       Impact factor: 1.438

5.  Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.

Authors:  Andrew J Muzyk; Amber Rayfield; Jane Y Revollo; Heather Heinz; Jane P Gagliardi
Journal:  Drug Saf       Date:  2012-07-01       Impact factor: 5.606

6.  Risk factors for QTc interval prolongation.

Authors:  Charlotte P M Heemskerk; Marieke Pereboom; Karlijn van Stralen; Florine A Berger; Patricia M L A van den Bemt; Aaf F M Kuijper; Ruud T M van der Hoeven; Aukje K Mantel-Teeuwisse; Matthijs L Becker
Journal:  Eur J Clin Pharmacol       Date:  2017-11-22       Impact factor: 2.953

7.  Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice.

Authors:  Young Choi; Hong-Seok Lim; Dahee Chung; Jung-Gu Choi; Dukyong Yoon
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

8.  Incidence and outcomes of long QTc in acute medical admissions.

Authors:  Rahel Mahmud; Adam Gray; Adam Nabeebaccus; Martin Brunel Whyte
Journal:  Int J Clin Pract       Date:  2018-09-17       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.